Eczema

Dupilmuab for Atopic Dermatitis Monitored With Noninvasive Imaging.

A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema

A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema

A Study to Learn About Abrocitinib Tablets in People With Atopic Dermatitis in India

Study of Abrocitinib Compared With Dupilumab in Adults With Moderate to Severe Atopic Dermatitis on Background Topical Therapy

Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema

Alitretinoin in the Treatment of Chronic Hand Eczema

Janus Kinase Inhibition in Granuloma Annulare

Janus Kinase Inhibition in Sarcoidosis

Study to Evaluate the Efficacy and Safety of ZL-3101 in Subjects With Subacute Eczema

A Study to Estimate the Effect of Multiple Dose Abrocitinib on Caffeine, Efavirenz, and Omeprazole in Healthy Participants

A Study Evaluating Relative Bioavailability of an Oral Suspension of Abrocitinib and Effect of an Acid Reducing Agent on the Bioavailability of Abrocitinib and Assessing the Taste of Abrocitinib Oral Formulations.

Real World Efficiency of Abrocitinib Treatment at Patients With Moderate to Severe Atopic Dermatitis Who Had Inadequate Response to Previous Biologic Therapies.

Abrocitinib Taiwan Treatment Pattern and Real World Study in ATopiC Dermatitis (ATTRACT Registry)

A Study of How Safe Abrocitinib (CIBINQO) is in Pregnant Women and Their Offspring

A Study to Learn About the Study Medicine (Called Cibinqo) in People With Atopic Dermatitis

A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis